Navigation Links
SemBioSys to present at the Needham & Company Biotechnology and Medical Technology Conference
Date:6/4/2008

TSX symbol: SBS

CALGARY, June 4 /PRNewswire-FirstCall/ - SemBioSys Genetics Inc. (TSX:SBS), a biotechnology company developing a portfolio of therapeutic proteins for metabolic and cardiovascular diseases, today announced that Andrew Baum, president & CEO of the company, will present a corporate update at the Needham & Company, LLC Seventh Annual Biotechnology and Medical Technology Conference. The presentation is scheduled on Wednesday, June 11 at 2:30 p.m., at the New York Palace Hotel.

Interested parties may access a live webcast of the presentation by visiting the company's website at http://www.sembiosys.com. Please connect at least 15 minutes prior to the presentation to ensure adequate time for any software download that may be required to join the webcast. An audio archive of the presentation will be available for approximately 30 days.

About SemBioSys Genetics Inc.

Calgary, Alberta-based SemBioSys Genetics Inc. is a biotechnology company developing protein-based pharmaceuticals for metabolic and cardiovascular diseases. The Company's lead pharmaceutical candidates, produced in the plant host safflower, are recombinant human insulin to serve the rapidly expanding global diabetes market and Apo AI, a next generation cardiovascular drug. In addition to its pharmaceutical products, SemBioSys' subsidiary, Botaneco, develops and supplies proprietary specialty ingredients to the personal care industry. More information is available at http://www.sembiosys.com.


'/>"/>
SOURCE SemBioSys Genetics Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1

Related biology technology :

1. SemBioSys updates Apo AI development program
2. SemBioSys to present insulin data at the Seventh Annual Diabetes Technology Meeting
3. SemBioSys announces 2007 third quarter results
4. SemBioSys signs option agreement for safflower-produced food ingredient
5. SemBioSys to present at the 10th Annual BIO CEO & Investor Conference
6. SemBioSys awarded key patent for the production of oleosome emulsions by the European Patent Office
7. SemBioSys GLA Partner Enters Strategic Alliance for the Sales and Marketing of GLA-Rich Safflower Oil
8. SemBioSys announces 2007 financial and operational results
9. SemBioSys initiates toxicology study for safflower-produced insulin
10. SemBioSys receives milestone payments from AVAC Ltd.
11. SemBioSys announces first quarter 2008 financial and operational results

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/6/2009)..., Calif., Nov. 6 ,, ...ansfer of Qutenza(TM) E.U. Marketing Authorization... progress in commercial readiness activities Expa...irector, Marketing; and Director, Commercial Opera...irector and Audit Committee chairman , Upco...
(Date:11/5/2009)...TION -- Gone hybrid . . . , Fuel economy ratin... posted at the www.fueleconomy.gov web site, whi...ntains for the U.S. Department of Energy and the U...op 10 vehicles on the best fuel economy list are h...ity; 48 highway). "This list proves that hybrids h...
(Date:11/5/2009)...RDOVA, Calif., Nov. 5 Th...lier of innovative products for processing and sto...the first quarter of fiscal 2010. ,, For the qu...ed revenues of $5.2 million, a 15 percent increase...r a year ago. The Company said the key contributor...
(Date:11/5/2009)...H, Texas, Nov. 5 Wound M...day that it has entered into a Letter of Intent to... Health Technologies, Inc. (OTC Bulletin Board: VH...000 in cash and debt, 4,000,000 shares of WNDM and...M on the Veriscrip technology being acquired from ...
Breaking Biology Technology:NeurogesX Reports Third Quarter 2009 Results 2NeurogesX Reports Third Quarter 2009 Results 3NeurogesX Reports Third Quarter 2009 Results 4NeurogesX Reports Third Quarter 2009 Results 5NeurogesX Reports Third Quarter 2009 Results 6NeurogesX Reports Third Quarter 2009 Results 7NeurogesX Reports Third Quarter 2009 Results 8NeurogesX Reports Third Quarter 2009 Results 9NeurogesX Reports Third Quarter 2009 Results 10November 2009 story tips from the US Department of Energy's Oak Ridge National Laboratory 2November 2009 story tips from the US Department of Energy's Oak Ridge National Laboratory 3ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 2ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 3ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 4ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 5ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 6ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 7ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 8OTCBB-WNDM Announces LOI to Acquire VHGI Assets for $10 Million Cash/Stock 2OTCBB-WNDM Announces LOI to Acquire VHGI Assets for $10 Million Cash/Stock 3
...pany (NYSE:,MON) announced today that it has recei...(TM) soybeans in Mexico, Australia and New Zealand... Safety Authority (EFSA) has,issued a positive sci...s,safe for import as food or feed. Roundup Ready 2...opular Roundup Ready(R) technology in soybeans,and...
... New Jersey, July 24, Rosetta Genomics Ltd. (Nasda...A-based diagnostics and therapeutics, announced,to...tion of Parkway,Clinical Laboratories Inc. ("Parkw...fied lab located in Bensalem, Pennsylvania, for an...g of $1,900,000 in cash and,$1,000,000 of Rosetta,...
...y will significantly change virtually every facet ...portunity to shape these changes and to ensure tha...its risks identified and controlled. A new report ...lays out a clear roadmap for the next presidential...nger term steps necessary to deal with the current...
Other Biology Technology:Monsanto Announces Key Regulatory Approvals for Roundup Ready 2 Yield(TM) Soybeans; Product Remains on Track for 2009 Launch 2Rosetta Genomics Completes Acquisition of Parkway Clinical Laboratories Inc. 2Rosetta Genomics Completes Acquisition of Parkway Clinical Laboratories Inc. 3Rosetta Genomics Completes Acquisition of Parkway Clinical Laboratories Inc. 4Rosetta Genomics Completes Acquisition of Parkway Clinical Laboratories Inc. 5Nanotech: A regulatory blueprint for the next administration 2
(Date:11/9/2009)...onducted in California and elsewhere provide suppo...naging fisheries and protecting marine habitats, a...rnia, Santa Cruz. , A recent study in the Gulf ... of a key concept behind marine reserves--the idea...eplenish the stocks of harvested species outside t...
(Date:11/9/2009)...ith cancer, the hopeful news is that pediatric sur...ong the bad newstreatments that enable survival of...ancer who have reached puberty currently have an o...ergoing cancer treatment, they may have their seme...s, however, do not produce sperm, although their t...
(Date:11/9/2009)...ary biologists David Queller and Joan Strassmann a...conflict between components, from the genetic leve...whether that thing is an animal, a plant, a bacter... use to describe an organism, such as individualit...be necessary to achieve organismality. What is nec...
Breaking Biology News(10 mins):Studies show marine reserves can be an effective tool for managing fisheries 2Studies show marine reserves can be an effective tool for managing fisheries 3Studies show marine reserves can be an effective tool for managing fisheries 4Studies show marine reserves can be an effective tool for managing fisheries 5For young boys with cancer, testicular tissue banking may be option to preserve fertility 2For young boys with cancer, testicular tissue banking may be option to preserve fertility 3What is the meaning of 'one'? 2What is the meaning of 'one'? 3High definition colonoscopy detects more polyps Mayo Clinic researchers say 60250 1High definition colonoscopy detects more polyps Mayo Clinic researchers say 60250 2Recovery Act funds expand studies of stem cell biology 10564 1Recovery Act funds expand studies of stem cell biology 10564 2EPAs new green parking lot allows scientists to study permeable surfaces that may help the environment 10560 1EPAs new green parking lot allows scientists to study permeable surfaces that may help the environment 10560 2
...ITHFUL women beware. Chances are your male partner... infidelities even when you have kept to the strai...his constant vigilance, women may be better than m...t Virginia Commonwealth University in Richmond and...nfidential questionnaires asking them whether they...
...human beings "blank slates" that are molded by the...ues and predispositions genetically based, shaped ...ion and human behaviour has been a hot topic of sc...e debate about the origin of our species 150 years...the fourth annual Lorne Trottier Public Science Sy...
...twist on nontraditional uses of ultrasound, a grou...as developed pulsed ultrasound techniques that can...findings, published in the Oct. 29 issue of the jo...ide insights into how low-power ultrasound can be ...brain circuits and offers the potential for new tr...
Other Biology News:Men are better at detecting infidelities 2What is the origin of ethics? 2Ultrasound shown to exert remote control of brain circuits 2Ultrasound shown to exert remote control of brain circuits 3
Rabbit Anti-Human Naked1 Polyclonal Antibody, Unconjugated from Cell Signaling Technology
Rabbit Anti-IRS1, phospho (Ser636) Polyclonal Antibody, Unconjugated from Abcam
Rabbit Anti-Streptococcus Enterotoxin C Polyclonal Antibody, Unconjugated from Abcam
Cultured Human Visceral (omental) preadipocytes from Zen-Bio, Inc.
Biology Products: